| Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a … M Shrotri, M Krutikov, T Palmer, R Giddings, B Azmi, S Subbarao, C Fuller, ... The Lancet Infectious Diseases 21 (11), 1529-1538, 2021 | 206 | 2021 |
| Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of COPD: a systematic review and meta-analysis E Moore, T Palmer, R Newson, A Majeed, JK Quint, MA Soljak Chest 150 (4), 837-859, 2016 | 102 | 2016 |
| Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study … M Krutikov, T Palmer, G Tut, C Fuller, B Azmi, R Giddings, M Shrotri, ... The Lancet Healthy Longevity 3 (1), e13-e21, 2022 | 99 | 2022 |
| Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study M Krutikov, T Palmer, G Tut, C Fuller, M Shrotri, H Williams, D Davies, ... The Lancet Healthy Longevity 2 (6), e362-e370, 2021 | 71 | 2021 |
| Effects of pulmonary rehabilitation on exacerbation number and severity in people with COPD: an historical cohort study using electronic health records E Moore, R Newson, M Joshi, T Palmer, KJ Rothnie, S Singh, A Majeed, ... Chest 152 (6), 1188-1202, 2017 | 56 | 2017 |
| Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study M Krutikov, O Stirrup, H Nacer-Laidi, B Azmi, C Fuller, G Tut, T Palmer, ... The Lancet Healthy longevity 3 (5), e347-e355, 2022 | 47 | 2022 |
| Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a … M Shrotri, M Krutikov, H Nacer-Laidi, B Azmi, T Palmer, R Giddings, ... The Lancet Healthy Longevity 3 (7), e470-e480, 2022 | 34 | 2022 |
| Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI) M Krutikov, T Palmer, A Donaldson, F Lorencatto, G Forbes, A Copas, ... Wellcome open research 5, 2020 | 31 | 2020 |
| Impacts of COVID-19-related service disruptions on TB incidence and deaths in Indonesia, Kyrgyzstan, Malawi, Mozambique, and Peru: Implications for national TB responses R Martin-Hughes, L Vu, N Cheikh, SL Kelly, N Fraser-Hurt, Z Shubber, ... PLOS Global Public Health 2 (3), e0000219, 2022 | 19 | 2022 |
| National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010–19: a data envelopment and stochastic frontier analysis GJ Abou Jaoude, IG Baena, P Nguhiu, A Siroka, T Palmer, L Goscé, ... The Lancet Global Health 10 (5), e649-e660, 2022 | 17 | 2022 |
| Understanding the lived experience of children with type 1 diabetes in Kenya: daily routines and adaptation over time T Palmer, C Waliaula, G Shannon, F Salustri, G Grewal, W Chelagat, ... Qualitative health research 32 (1), 145-158, 2022 | 13 | 2022 |
| Effectiveness of conditional cash transfers (Afya credits incentive) to retain women in the continuum of care during pregnancy, birth and the postnatal period in Kenya: a … F Vanhuyse, O Stirrup, A Odhiambo, T Palmer, S Dickin, J Skordis, ... BMJ open 12 (1), e055921, 2022 | 11 | 2022 |
| Conditional cash transfers to retain rural Kenyan women in the continuum of care during pregnancy, birth and the postnatal period: protocol for a cluster randomized controlled … CA Ochieng, H Haghparast-Bidgoli, N Batura, A Odhiambo, G Shannon, ... Trials 20, 1-15, 2019 | 11 | 2019 |
| Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI) O Stirrup, M Shrotri, NL Adams, M Krutikov, H Nacer-Laidi, B Azmi, ... Open Forum Infectious Diseases 10 (1), ofac694, 2023 | 9 | 2023 |
| Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021 R Giddings, M Krutikov, T Palmer, C Fuller, B Azmi, M Shrotri, ... Eurosurveillance 26 (46), 2100995, 2021 | 8 | 2021 |
| Optima TB: A tool to help optimally allocate tuberculosis spending L Goscé, GJ Abou Jaoude, DJ Kedziora, C Benedikt, A Hussain, S Jarvis, ... PLoS computational biology 17 (9), e1009255, 2021 | 8 | 2021 |
| Technical efficiency of national HIV/AIDS spending in 78 countries between 2010 and 2018: A data envelopment analysis K Allel, GJ Abou Jaoude, C Birungi, T Palmer, J Skordis, ... PLOS Global Public Health 2 (8), e0000463, 2022 | 6 | 2022 |
| Severe acute respiratory syndrome coronavirus 2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 vaccine in residents of long-term care … O Stirrup, M Krutikov, G Tut, T Palmer, D Bone, R Bruton, C Fuller, B Azmi, ... The Journal of Infectious Diseases 226 (11), 1877-1881, 2022 | 5 | 2022 |
| Improving access to diabetes care for children: An evaluation of the changing diabetes in children project in Kenya and Bangladesh T Palmer, HM Jennings, G Shannon, F Salustri, G Grewal, W Chelagat, ... Pediatric Diabetes 23 (1), 19-32, 2022 | 5 | 2022 |
| Protocol for the cost-consequence and equity impact analyses of a cluster randomised controlled trial comparing three variants of a nutrition-sensitive agricultural extension … H Haghparast-Bidgoli, J Skordis, H Harris-Fry, S Krishnan, M O’Hearn, ... Trials 20, 1-11, 2019 | 5 | 2019 |
